All Categories
  • All Categories
  • Accessories
  • Accessories & More
  • Butters & Eggs
  • Camera & Video
  • Mornitors
  • Tablets
  • Laptops
  • Handbags
  • Headphone & Speaker
  • Herbs & botanicals
  • Vegetables
  • Shop
  • Laptops & Desktops
  • Watchs
  • Electronic
standards@synzeal.com

Blog

Blog archive

2020

May (1)

June (1)

August (2)

September (1)

October (7)

November (3)

2021

January (9)

February (2)

March (7)

April (1)

May (1)

June (4)

July (2)

August (2)

September (3)

December (2)

2022

January (4)

February (3)

March (5)

April (5)

May (1)

2023

July (2)

Exciting News! SynZeal Exhibiting at CPhI Barcelona 2023!

Date Wednesday, July 26, 2023 /

Exciting News! SynZeal Exhibiting at CPhI Barcelona 2023!

 

We are excited to announce that SynZeal will be exhibiting at CPhI Worldwide Barcelona 2023 – the pharmaceutical industry's premier event!

 

📅 Event Details:

📍 Location: Fira de Barcelona, Barcelona, Spain

🗓️ Dates: 24-26th Oct 23

🗓️ Booth No: 7K61

 

CPhI Worldwide is one of the most anticipated events in the pharmaceutical sector, attracting top professionals, industry experts, and companies from around the globe. As a leading player in the Pharmaceutical Reference Standards, this event is the perfect platform for us to showcase the latest development, products, and services.

 

Our team of experts will be available during the event to interact with industry peers and collaborators and discuss research solutions that will prove useful in accelerating research projects. We'll be highlighting our commitment to quality, innovation, and drive to make a positive impact on your research goals.

 

SynZeal has been at the forefront of the development of Pharmaceutical Reference Standards for over a decade. Our success is a testament to our dedicated team and the trust we've built with our customers. We look forward to connecting with industry experts like you, exploring potential synergies, and discussing how we can collaborate for mutual growth and advancement.

 

If you're attending CPhI Barcelona 2023, we'd love to meet you in person! Feel free to schedule a meeting with our team in advance by sending us e-mail to standards@synzeal.com or schedule meeting now.

 

We can't wait to have meaningful conversations and explore exciting business opportunities together.

See you in Barcelona!

 

Read More

SynZeal is exhibiting at Analitica Latin America 2023 in São Paulo!

Date Wednesday, July 26, 2023 /

SynZeal is exhibiting at Analitica Latin America 2023 in São Paulo!

 

SynZeal is delighted to announce participation as an exhibitor at Analitica Latin America 2023, the premier event for laboratory technology and analytical science, to be held in São Paulo, Brazil!

 

📅 Event Details:

📍 Location: São Paulo Expo, São Paulo, Brazil

🗓️ Dates: 26-27-28 Sep 23

🗓️ Booth No: H056

 

Analitica Latin America is the pinnacle of innovation, drawing leading experts, professionals, and businesses from the analytical industry to showcase the latest advancements. As a key player in the field of Pharmaceutical Reference standards, we couldn't miss this opportunity to join the industry experts in exploring prospective collaboration.

 

At SynZeal, our commitment to the highest quality products & service is unwavering. At Analitica Latin America 2023, we'll be presenting the latest development at SynZeal. Our team of experts is excited to engage with industry peers and establish valuable partnerships.

 

If you're attending Analitica Latin America 2023, be sure to visit us at Booth H056. We'd love to meet you in person and discuss our innovative solutions for accelerating research projects. Schedule a meeting with our team in advance by sending a direct message to this e-mail, us an e-mail to standards@synzeal.com or schedule a meeting now.

 

We look forward to connecting with all of you at Analitica Latin America 2023.

Let's Connect! 

 

Read More

Fluocinonide

Date Thursday, May 5, 2022 /

Fluocinonide is a synthetic glucocorticoid and derivative of fluocinolone acetonide with anti-inflammatory and antipruritic activities. Fluocinonide is a potent glucocorticoid used topically as an anti-inflammatory agent for the treatment of skin disorders such as eczema and seborrhoeic dermatitis.

 

SynZeal offers all  Fluocinonide related impurities standards with certified COA and characterization data like IR, Mass, HPLC, purity, NMR & TGA report. We also provide CMR, DEPT and detailed structure characterization report as per requirements. Fluocinonide related standards are being used by major pharmaceutical companies across the globe for their ANDA/DMF filing.

 

Read More

Fluocinolone

Date Thursday, April 28, 2022 /

Fluocinolone binds the glucocorticoid receptor, followed by translocation of the ligand-receptor complex to the nucleus and transcription activation of genes containing glucocorticoid-responsive elements. Fluocinolone has been used in trials studying the treatment and prevention of Candida Infection, Oral Lichen Planus, Macular Degeneration, and Choroidal Neovascularization. It was patented in 1958 and approved for medical use in 1961.

 

SynZeal offers allFluocinolone related impurities standards with certified COA and characterization data like IR, Mass, HPLC, purity, NMR & TGA report. We also provide CMR, DEPT and detailed structure characterization report as per requirements. Fluocinolone related standards are being used by major pharmaceutical companies across the globe for their ANDA/DMF filing.

 

Read More

Fesoterodine

Date Friday, April 22, 2022 /

Fesoterodine also known as toviaz, belongs to the class of organic compounds known as diphenylmethanes. Fesoterodine is a competitive muscarinic receptor antagonist with muscle relaxant and urinary antispasmodic properties. It was approved by the European Medicines Agency in April 2007

 

SynZeal offers all  Fesoterodine related impurities standards with certified COA and characterization data like IR, Mass, HPLC, purity, NMR & TGA report. We also provide CMR, DEPT and detailed structure characterization report as per requirements. Fesoterodine related standards are being used by major pharmaceutical companies across the globe for their ANDA/DMF filing.

 

Read More

Exemestane

Date Thursday, April 14, 2022 /

Exemestane binds irreversibly to and inhibits the enzyme aromatase, thereby blocking the conversion of cholesterol to pregnenolone and the peripheral aromatization of androgenic precursors into estrogens. Exemestane is a drug which is used for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy. FDA approval was in October 2005.

 

SynZeal offers allExemestane related impurities standards with certified COA and characterization data like IR, Mass, HPLC, purity, NMR & TGA report. We also provide CMR, DEPT and detailed structure characterization report as per requirements. Exemestane related standards are being used by major pharmaceutical companies across the globe for their ANDA/DMF filing.

 

Read More

Ezetimibe

Date Friday, April 8, 2022 /

Ezetimibe is a lipid-lowering compound that inhibits intestinal cholesterol and phytosterol absorption. Ezetimibe is used as an adjunctive therapy to a healthy diet to lower cholesterol levels in primary hyperlipidemia, mixed hyperlipidemia, homozygous familial hypercholesterolemia (HoFH), and homozygous sitosterolemia (phytosterolemia). Ezetimibe was approved for medical use in the United States in 2002.

 

SynZeal offers allEzetimibe related impurities standards with certified COA and characterization data like IR, Mass, HPLC, purity, NMR & TGA report. We also provide CMR, DEPT and detailed structure characterization report as per requirements. Ezetimibe related standards are being used by major pharmaceutical companies across the globe for their ANDA/DMF filing.

 

Read More

Etonogestrel

Date Thursday, March 31, 2022 /

Etonogestrel molecule is a 3-ketodesogestrel or 19-nortestosterone which is a synthetic biologically active metabolite of progestin desogestrel.Etonogestrel is a drug which is used for use as a female contraceptive. Etonogestrel was patented in 1972 and introduced for medical use in 1998.

 

SynZeal offers all  Etonogestrel related impurities standards with certified COA and characterization data like IR, Mass, HPLC, purity, NMR & TGA report. We also provide CMR, DEPT and detailed structure characterization report as per requirements. Etonogestrel related standards are being used by major pharmaceutical companies across the globe for their ANDA/DMF filing.

 

Read More

Etodolac

Date Thursday, March 24, 2022 /

Etodolac is a pyranocarboxylic acid and non-steroidal anti-inflammatory drug (NSAID) with antipyretic and analgesic activities. Etodolac used for the management of mild to moderate pain, fever, and inflammation. It was patented in 1971 and approved for medical use in 1985.

 

SynZeal offers all  Etodolac related impurities standards with certified COA and characterization data like IR, Mass, HPLC, purity, NMR & TGA report. We also provide CMR, DEPT and detailed structure characterization report as per requirements. Etodolac related standards are being used by major pharmaceutical companies across the globe for their ANDA/DMF filing.

 

Read More

Ethinylestradiol

Date Wednesday, March 16, 2022 /

Ethinylestradiol is a semisynthetic estrogen. Ethinyl estradiol binds to the estrogen receptor complex and enters the nucleus, activating DNA transcription of genes involved in estrogenic cellular responses. Ethinylestradiol medication which is used widely in birth control pills in combination with progestins. Ethinylestradiol was developed in the 1930s and was introduced for medical use in 1943.

 

SynZeal offers all Ethinylestradiol related impurities standards with certified COA and characterization data like IR, Mass, HPLC, purity, NMR & TGA report. We also provide CMR, DEPT and detailed structure characterization report as per requirements. Ethinylestradiol related standards are being used by major pharmaceutical companies across the globe for their ANDA/DMF filing.

 

Read More